Cigna Group $CI Stock Sold by HighTower Advisors LLC

HighTower Advisors LLC reduced its position in Cigna Group (NYSE:CI – Free Report) by 1.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 348,649 shares of the health services provider’s stock after selling 5,749 shares during the quarter. HighTower Advisors LLC’s holdings in Cigna Group were worth $94,773,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. BlackRock Inc. increased its holdings in Cigna Group by 3.7% in the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after buying an additional 840,098 shares during the period. GQG Partners LLC bought a new position in shares of Cigna Group during the 2nd quarter worth about $1,628,918,000. Bank of America Corp DE lifted its holdings in shares of Cigna Group by 8.8% during the 1st quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock worth $848,821,000 after acquiring an additional 256,677 shares during the period. Legal & General Group Plc acquired a new stake in shares of Cigna Group during the 2nd quarter valued at about $542,779,000. Finally, Amundi boosted its position in shares of Cigna Group by 10.7% during the 2nd quarter. Amundi now owns 1,715,636 shares of the health services provider’s stock valued at $472,966,000 after acquiring an additional 165,633 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling

In other Cigna Group news, insider Everett Neville sold 617 shares of the business’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the transaction, the insider directly owned 5,053 shares in the company, valued at $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Cigna Group Stock Down 2.0%

Shares of NYSE CI opened at $294.02 on Wednesday. The stock has a market cap of $77.47 billion, a PE ratio of 9.49, a PEG ratio of 1.12 and a beta of 0.25. The business has a fifty day moving average of $288.24 and a two-hundred day moving average of $282.95. Cigna Group has a 52-week low of $257.85 and a 52-week high of $318.05. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74.

Cigna Group (NYSE:CI – Get Free Report) last issued its earnings results on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, beating the consensus estimate of $7.52 by $0.46. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The company had revenue of $73.79 billion for the quarter, compared to the consensus estimate of $72.64 billion. During the same quarter in the previous year, the company earned $7.83 EPS. The firm’s revenue for the quarter was up 5.6% compared to the same quarter last year. As a group, equities research analysts expect that Cigna Group will post 30.71 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, December 3rd. Cigna Group’s dividend payout ratio (DPR) is currently 27.54%.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Barclays upped their target price on shares of Cigna Group from $310.00 to $320.00 and gave the company an “equal weight” rating in a research note on Monday, November 9th. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research note on Thursday, August 27th. Jefferies Financial Group lifted their price objective on Cigna Group from $288.00 to $304.00 and gave the company a “hold” rating in a report on Thursday, November 12th. Evercore assumed coverage on Cigna Group in a report on Wednesday, September 9th. They set an “in-line” rating and a $290.00 price objective on the stock. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $337.00 price objective on shares of Cigna Group in a research note on Thursday, October 1st. Fourteen research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $336.90.

Get Our Latest Research Report on CI

Cigna Group Company Profile

(Free Report)

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.